AusCann (ACNNF)

[Bizdoc]

Good morning follow Auscann investors. Here's a very nice article updating the top 20 cannabis companies in Australia. Auscann came in 6th place on the list--that's pretty impressive! https://www.businessnewsaus.com.au/articles/australia-s-top-20-cannabis-companies.html

[Darius Demian]

Hopefully. We've been waiting patiently.

[jaxdawson63]

One step at a time. With the new CEO aboard hopefully things star moving now :)

JAX

[Diogenes of Sinope]

BRIEF-Auscann Group Signs Supply Agreement For Purchase Of Cannabis Resin From Tasmanian Alkaloids

https://auscann.cmail19.com/t/ViewEmail/j/3988948B1D9978D92540EF23F30FEDED/6CB87BB6F4FA761D40EE66FE10287772

[jaxdawson63]

Number #6 on top 20 Australian cannibis companies:)

https://www.businessnewsaus.com.au/articles/australia-s-top-20-cannabis-companies.html

JAX

[OSOROJO]

It’s only a matter of of time and patience, https://apple.news/AClbKQQtVRNyAQf4r-KMB1w

[LoserTrying2Win]

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

https://finance.yahoo.com/news/medipharm-labs-receives-permits-ships-103000545.html


TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (LABS.V) (MEDIF) (MLZ.F) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce it successfully completed its first export shipment of medical cannabis concentrate into Australia to AusCann Group Holdings Ltd. Through its wholly owned subsidiary, MediPharm Labs Inc., the Company has become the first Canadian extraction-only company to publicly announce that it has received an export permit from Health Canada for the shipment of cannabis solid concentrate, under the new regulations, from Canada to Australia. Prior to the shipment, the Australian Government’s Office of Drug Control Section also issued an import permit.

“As we look to remain a global leader in cannabinoid extraction, we are proud to have completed our first international shipment of MediPharm Labs’ cannabis concentrates to Australia,” said Pat McCutcheon, Chief Executive Officer, MediPharm Labs. “We expect to see international demand, including in Europe and Australia, for MediPharm Labs’ cannabis concentrates continue to grow as our team has built a strong reputation for producing high quality, pharmaceutical like concentrates at commercial scale and proven our ability to ensure a global supply chain. We are excited to be completing our EU GMP certification which will enable us to export to Europe and tap into these additional sources of demand.”

About MediPharm Labs Corp.

Founded in 2015, MediPharm Labs Inc. has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates begins in its purpose-built laboratory designed to incorporate EUGMP (European Good Manufacturing Practices) workflow and ISO standard-built clean rooms and critical environments, allowing MediPharm Labs to produce purified, pharmaceutical-like cannabis oil and concentrates for advanced derivative products. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream extraction methodologies and purpose-built facilities to deliver pure, safe and precisely-dosed cannabis products to patients and consumers. MediPharm Labs’ private label program is a high margin business for the company, whereby it opportunistically procures dry cannabis flower and trim from its numerous product supply partners, to produce cannabis oil concentrate products for resale globally on a private label basis.

For further information, please contact:
Laura Lepore, VP, Investor Relations
Telephone: [phone] ext 216
Email: [e-mail]
Website: www.medipharmlabs.com

[LoserTrying2Win]

Weird it's still flying under the rader after that news. Just on that headline alone there should be people interested in checking this out.

[motorcityAce]

No ...its got todays date on it.. Im already loaded..

[Bed Bath & Beyonce]

Is this story about CGC increasing stake of ACNNF to 13.28% old or new news?

https://www.proactiveinvestors.com/companies/news/221926/auscann-group-substantial-shareholder-lifts-interest-to-1328-221926.html

[cottonmather]

Probable bounce. A reliable technical condition has printed. http://schrts.co/gBDQZkWB

[Diogenes of Sinope]

ACNNF—We wait—GLTA!

[Diogenes of Sinope]

AusCann Group's new chief executive officer Ido Kanyon takes up role

https://ca.proactiveinvestors.com/companies/news/220730/auscann-group-s-new-chief-executive-officer-ido-kanyon-takes-up-role-220730.html

[LoserTrying2Win]

Agree and am surprised this isn't getting more attention.

[lazur]

now that medif is supplying Auscann this becomes a more interesting play at these prices. I bought long ago due to the canopy tie in and just have let the shares sit. Now I may actually add, as this is a great doorway into the Aus maket for other companies, profiting all.

[LoserTrying2Win]

Right..I wouldn't be surprised if we see a dollar again within a year as my eyes discover this.

[Bizdoc]

His cannabis stock pick for 2019 is AC8!

https://green.cannabisstocktrades.com/my-2019-stock-pick?a_aid=focus&a_bid=5a4efa9e

[LoserTrying2Win]

Some decent buys here today

[LoserTrying2Win]

At this price I"m surprised this isn't on more peoples radar. Easily the best risk/reward MJ play out there right now, as this is actually a real company.

[LoserTrying2Win]

Was here a while ago ...Re opened position today...I think it's go time here.

[Diogenes of Sinope]

AusCann continues its transition to a pharmaceutical manufacturing and sales company during the March Quarter

https://auscann.cmail19.com/t/ViewEmail/j/8E640BB87C5CDF252540EF23F30FEDED/6CB87BB6F4FA761D40EE66FE10287772

[Trons]

Boom time

[tmonkey]

up 3 cents in sydney on much bigger volume than we get on this side of the pond!!-and the concensus there is the big escrow sell off is next to over -cant believe people could still get in for under .30 yesterday---if i only had any powder i would have shot my wad---after today i am at a profit after buying in the low .30s on the way down--- ---now they can come with a news stream to help lift off-------tmonkey

[Trons]

Added at .3

[tmonkey]

when i woke up this morning she was on my mind!---UP over 9 % in sydney on almost 4 mil.vol.!has this worm turned??---i should be up on my position at eod and look for alot more!----if i had more powdwe id throw it in now but i was ALL in awhile ago-----tmonkey

[tmonkey]

if the pps is up again in sydney this will blow thru .30 on monday-------over 100 mill sh out of escrow have been absorbed and most likely the rest wont be thrown on the mkt at these low prices---with the selling drying up maybe there will be a series of pr-s to further fuel a rise in the pps??why waste them in the big dump of shares that has taken place!!-------anywho-----im all in here at a pps near the close today and happy with it-----tmonkey

[tmonkey]

good day today!!--im back up to my avg----having gotten bored waiting at .32------got my avg down to pps now and ready for a turn around----hope everyone on board here!!-----------tmonkey

[Diogenes of Sinope]

ACNNF—Moving nicely off the bottom

[Darius Demian]

Finally! :) Can't complain...she gave us plenty of time to accumulate. Ready for blast of now. :)

[CES2002]

Looks like recovery mode has started, big day today!

[jaxdawson63]

People asleep at the switch? As soon as the sheep wake they’ll be licking there little lamby chops to get in. I believe things are about to pop in not too distant future. :) those cheapies won’t last long.

JAX

[tmonkey]

great prices here----almost no profit for the rest of the escrow shares!!-it beats me why sellers didnt hit this hard and fast right from the get go----feb 4-to get the most profit from cost of .21???----now they might take a loss if they really need funds??--A mystery to me--glta------------tmonkey

[CES2002]

HUGE volume again, maybe all shares will go fast and we start to recover.

[TheGreatGreenRush]

Already released. Check my sticky

[CES2002]

when is the release date?

[TheGreatGreenRush]

Neither. It’s 100m shares coming to market at $.21

[CCjetset]

Monkey said that this may happen. I’ve had an order in at .23.
Thanks for the heads up!

[CES2002]

Being walked down to .21 for some reason, is it fundamentals or MM games? Wish I knew.

[CCjetset]

Under .23 today? Ty

[tmonkey]

Great info comin here under .23 o
I sell others and buy the co
Tmonkey

[CES2002]

Latest Investor Presentation March 2019
https://clients3.weblink.com.au/pdf/AC8/02084039.pdf

[OSOROJO]

https://thegreenfund.com/green-states-a-state-by-state-guide-to-australian-cannabis

[OSOROJO]

F.Y.I.
While the Australian cannabis market has made great strides over the last two years, it is still in an embryonic stage of development. Despite arriving moderately late in the game, the country is well positioned to become a major global player in the export market—which is expected to be worth $55 billion by 2025—on the back of its’ already thriving agricultural sector.

Although Australia only legalised marijuana exports in 2018, it already has plenty of experience in the agri-phrama business and is responsible for approximately 50 percent of the world’s legal poppy supply. These poppies eventually are processed by pharmaceutical companies into medical grade opiates such as codeine and morphine.

However, the country still has several hurdles to overcome if it wants to fulfill its ambition of dominating the global cannabis export market, such as heavy financing requirements, a repressive and convoluted licensing system, and a medical profession that is reluctant to prescribe the product.

Data from the Ministry of Health shows that despite the legalisation of medicinal marijuana in 2017, the number of patients being prescribed cannabis is still lagging behind other countries.

Additionally, much of the market demand is currently centered around North America and Europe, leaving Australian suppliers with a geographical freight disadvantage. To counter this, many companies are positioning themselves as premium product producers, similar to the country’s thriving agricultural industry.

The nascent Asian market is also beginning to gradually expand, following the 2018 legalisation of medical marijuana in Thailand and South Korea. In recent years countries such as China, Japan, and Indonesia have also become some of Australia’s biggest trading partners.

Considering Australia’s close geographic proximity to the region, it seems likely that local suppliers will be well-positioned to capitalise on Asia’s growing cannabis market as it begins to reach maturation.

Australian cannabis stocks started last year on a high—following the announcement that government would be legalising marijuana exports—however, most shares spent the following twelves months in freefall. This was partly the result of an ongoing downturn that affected much of the industry, as some traders became nervous in response to growing market volatility.

This has left many pot stocks highly undervalued, which is good news for long position investors who are looking to buy into the sector, or consolidate their investment—while incurring minimal costs—if they are willing to ride out the market fluctuations.

[CCjetset]

I hear ya. Best of luck brother!

[tmonkey]

bt my last bunch today------really didnt think we would keep falling so far off from the release from escrow but with the pps today im further under .30 and dead out of powder now----now we can get a big buyout offer after the close!!glta-------tmonkey

[CCjetset]

Agreed. Thanks

[Darius Demian]

Just added significantly myself. Risk/Reward is totally worth it imo.

[TheGreatGreenRush]

It's stealing now

Buy the blood people!

Hard to say where the exact bottom is. Somewhere between $.21 and current price. Could float down a little more

[CCjetset]

I’m nibbling on the way down .28, .265 and now looks like .245 may be in my future. LOVIN IT !

[TheGreatGreenRush]

Yes they are Madd. Hard to point to an exact bottom with the share offering at $.21. Could float down a little more but anything under $.30 is an absolute steal.